Brind.
  1. Quest Diagnostics and other health companies are consolidating the lab market through acquisitions and joint ventures.

Quest Diagnostics acquired clinical testing assets from Fresenius Medical Care to provide dialysis-related lab services.

3 reports, 2 independent Updated Sep 21
Gone quiet
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Quest Diagnostics acquired clinical testing assets from Fresenius Medical Care to provide dialysis-related lab services.

Who's involved

What this event is mainly about
Quest DiagnosticsFresenius Medical Care

How it developed

Newest first. Tap a step to see who reported it.
  1. Corewell, Quest, and Fresenius finalize a major co-lab and dialysis business absorption deal.1 source
  2. Quest acquired Fresenius testing assets to provide dialysis lab services.1 source

Keep exploring

Part of

Quest Diagnostics and other health companies are consolidating the lab market through acquisitions and joint ventures. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • themarketsdaily.com
  • PR NewswireQuest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care SECAUCUS, N.J., Aug. 5, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagno
1 more outlet ran the same wire story